Swiss National Bank Has $221.98 Million Holdings in Cigna Group $CI

Swiss National Bank lowered its stake in shares of Cigna Group (NYSE:CI) by 6.2% in the third quarter, according to its most recent 13F filing with the SEC. The fund owned 770,101 shares of the health services provider’s stock after selling 50,600 shares during the period. Swiss National Bank owned approximately 0.29% of Cigna Group worth $221,982,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in CI. Pathway Financial Advisers LLC lifted its holdings in shares of Cigna Group by 2.3% in the second quarter. Pathway Financial Advisers LLC now owns 1,501 shares of the health services provider’s stock valued at $496,000 after purchasing an additional 34 shares in the last quarter. Armstrong Advisory Group Inc. grew its holdings in Cigna Group by 17.7% during the third quarter. Armstrong Advisory Group Inc. now owns 226 shares of the health services provider’s stock worth $65,000 after buying an additional 34 shares in the last quarter. HM Payson & Co. raised its position in Cigna Group by 0.9% in the 3rd quarter. HM Payson & Co. now owns 3,785 shares of the health services provider’s stock valued at $1,091,000 after buying an additional 35 shares during the last quarter. Carr Financial Group Corp raised its position in Cigna Group by 5.3% in the 3rd quarter. Carr Financial Group Corp now owns 709 shares of the health services provider’s stock valued at $204,000 after buying an additional 36 shares during the last quarter. Finally, Natural Investments LLC lifted its stake in Cigna Group by 2.0% during the 3rd quarter. Natural Investments LLC now owns 1,843 shares of the health services provider’s stock valued at $531,000 after acquiring an additional 36 shares in the last quarter. 86.99% of the stock is owned by institutional investors.

Insider Activity at Cigna Group

In related news, insider Nicole S. Jones sold 2,307 shares of the company’s stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total value of $666,515.37. Following the transaction, the insider owned 32,647 shares in the company, valued at approximately $9,432,044.77. This represents a 6.60% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Everett Neville sold 1,719 shares of the stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total value of $496,636.29. Following the transaction, the insider directly owned 5,670 shares of the company’s stock, valued at approximately $1,638,119.70. This trade represents a 23.26% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Company insiders own 0.70% of the company’s stock.

Cigna Group Trading Down 0.8%

Shares of Cigna Group stock opened at $269.57 on Tuesday. The firm has a market cap of $71.04 billion, a PE ratio of 12.15, a P/E/G ratio of 0.94 and a beta of 0.27. Cigna Group has a 1 year low of $239.51 and a 1 year high of $350.00. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.74 and a quick ratio of 0.74. The stock has a fifty day moving average price of $280.58 and a 200-day moving average price of $283.75.

Cigna Group (NYSE:CI) last posted its quarterly earnings results on Thursday, February 5th. The health services provider reported $8.08 earnings per share for the quarter, beating the consensus estimate of $7.88 by $0.20. Cigna Group had a net margin of 2.17% and a return on equity of 19.46%. The company had revenue of $72.50 billion during the quarter, compared to analyst estimates of $69.53 billion. During the same quarter in the prior year, the business earned $6.64 earnings per share. The firm’s revenue for the quarter was up 10.4% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.250- EPS. Equities research analysts anticipate that Cigna Group will post 29.77 EPS for the current year.

Cigna Group Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, March 19th. Stockholders of record on Thursday, March 5th will be given a dividend of $1.56 per share. The ex-dividend date of this dividend is Thursday, March 5th. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.3%. This is an increase from Cigna Group’s previous quarterly dividend of $1.51. Cigna Group’s payout ratio is currently 28.13%.

Analysts Set New Price Targets

A number of equities analysts have issued reports on CI shares. Deutsche Bank Aktiengesellschaft lifted their price objective on shares of Cigna Group from $301.00 to $304.00 and gave the stock a “buy” rating in a report on Tuesday, February 10th. Piper Sandler dropped their price target on shares of Cigna Group from $374.00 to $370.00 and set an “overweight” rating on the stock in a research report on Tuesday, March 3rd. Leerink Partners boosted their price target on shares of Cigna Group from $270.00 to $297.00 and gave the stock a “market perform” rating in a report on Friday, February 6th. TD Cowen upped their price objective on shares of Cigna Group from $333.00 to $338.00 and gave the stock a “buy” rating in a research report on Monday, February 9th. Finally, Guggenheim reiterated a “buy” rating and issued a $318.00 price objective on shares of Cigna Group in a research note on Monday, February 2nd. One investment analyst has rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and five have assigned a Hold rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $330.42.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.